Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB01072_DB01142_nanopub.RApsC8qSj-aAH1pji3uKA51mlqWGBPR-aGWAPG8HLCtkQ#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB01072_DB01142 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB01072_DB01142 label "DDI between Atazanavir and Doxepin - Atazanavir may increase the effect and toxicity of the tricyclic antidepressant, doxepin, by decreasing its metabolism. Monitor for changes in the therapeutic and adverse effects of doxepin if atazanavir if initiated, discontinued or dose changed. [drugbank_resource:DB01072_DB01142]" assertion.
- drugbank_resource:DB01072_DB01142 identifier "drugbank_resource:DB01072_DB01142" assertion.
- drugbank_resource:DB01072_DB01142 title "DDI between Atazanavir and Doxepin - Atazanavir may increase the effect and toxicity of the tricyclic antidepressant, doxepin, by decreasing its metabolism. Monitor for changes in the therapeutic and adverse effects of doxepin if atazanavir if initiated, discontinued or dose changed." assertion.
- drugbank:DB01072 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01072_DB01142 assertion.
- drugbank:DB01142 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01072_DB01142 assertion.